209 related articles for article (PubMed ID: 15877799)
1. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
Akalin E; Ames S; Sehgal V; Murphy B; Bromberg JS
Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
[TBL] [Abstract][Full Text] [Related]
2. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
[TBL] [Abstract][Full Text] [Related]
4. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
Sumethkul V; Ingsathit A; Jirasiritham S
Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
[TBL] [Abstract][Full Text] [Related]
7. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
[TBL] [Abstract][Full Text] [Related]
8. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
[TBL] [Abstract][Full Text] [Related]
9. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
[TBL] [Abstract][Full Text] [Related]
10. Safe use of livers from donors with positive hepatitis B core antibody.
Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
[TBL] [Abstract][Full Text] [Related]
11. Heart transplantation using donors positive for hepatitis.
Wang SS; Chou NK; Ko WJ; Yu HY; Chen YS; Hsu RB; Huang SC; Chi NH; Tsao CI; Lai MY; Liau CS; Lee YT
Transplant Proc; 2004 Oct; 36(8):2371-3. PubMed ID: 15561252
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
[TBL] [Abstract][Full Text] [Related]
13. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
[TBL] [Abstract][Full Text] [Related]
14. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
Kim JA; Huh W; Lee KW; Kim SJ; Kim YG; Kim DJ; Joh JW; Oh HY
Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
[TBL] [Abstract][Full Text] [Related]
15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
18. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
Skagen CL; Jou JH; Said A
Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
[TBL] [Abstract][Full Text] [Related]
19. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
[TBL] [Abstract][Full Text] [Related]
20. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]